CA
SRTS icon

Clearstead Advisors’s Sensus Healthcare SRTS Stock Holding History

Clearstead Advisors’s Portfolio SRTS Stock Details SRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$617 Hold
155
– – ﹤0.01% 2098
2025
Q4 		$617 Buy
+155
New +$574 ﹤0.01% 2290

Other funds holding SRTS

PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
GWM
Greenline Wealth Management Boca Raton, Florida $86.7M AUM

Clearstead Advisors's SRTS Position: Q1 2026 in Review

Clearstead Advisors held its Sensus Healthcare (SRTS) position steady in Q1 2026 at 155 shares worth $617. The position accounts for ﹤0.01% of the portfolio, ranked #2098.

Clearstead Advisors first reported a position in SRTS in Q4 2025 and has held it in 2 quarters since. 41 funds tracked by Wall St. Rank hold SRTS as of Q1 2026.

  • Clearstead Advisors held 155 shares of Sensus Healthcare worth $617 as of Q1 2026.
  • Clearstead Advisors left its Sensus Healthcare share count unchanged in Q1 2026.
  • Sensus Healthcare made up ﹤0.01% of Clearstead Advisors's portfolio in Q1 2026, its #2098 holding.
  • Clearstead Advisors first reported a position in Sensus Healthcare in Q4 2025 and has held it in 2 quarters since.
  • 41 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2026.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.